Kern A, Barabás E, Balog A, Burcsár Sz, Kiszelák M, Vásárhelyi B
1 Department of Laboratory Medicine, Faculty of Medicine, Semmelweis University , Budapest, Hungary.
2 Diagon Ltd. , Budapest, Hungary.
Physiol Int. 2017 Mar 1;104(1):35-41. doi: 10.1556/2060.104.2017.1.5.
Systemic lupus erythematosus (SLE) is a multisystemic inflammatory autoimmune disorder. Thrombotic events occur at a higher incidence among SLE patients. The investigation of thrombin generation (TG) with calibrated automated thrombogram (CAT) test as a global hemostasis assay is applicable for the overall functional assessment of the hemostasis. The aim of this study was to characterize the hemostatic alterations observed in SLE by CAT assay. In this study, CAT parameters and basic coagulation parameters of SLE patients (n = 22) and healthy control subjects (n = 34) were compared. CAT area under the curve (i.e., endogenous thrombin potential) was lower than normal in SLE (807 vs. 1,159 nM*min, respectively), whereas other CAT parameters (peak, lag time, time to peak, and velocity index) and the basic coagulation tests were within the normal range. The presence of anti-phospholipid antibodies and the applied therapy was not associated with hemostasis parameters in SLE. We concluded that the reported high risk of thrombosis is not related to TG potential.
系统性红斑狼疮(SLE)是一种多系统炎症性自身免疫性疾病。血栓形成事件在SLE患者中的发生率较高。用校准自动血栓图(CAT)试验作为一种全面的止血检测方法来研究凝血酶生成(TG),适用于对止血功能进行整体评估。本研究的目的是通过CAT试验来描述SLE患者所观察到的止血改变。在本研究中,对SLE患者(n = 22)和健康对照者(n = 34)的CAT参数和基本凝血参数进行了比较。SLE患者的CAT曲线下面积(即内源性凝血酶潜力)低于正常水平(分别为807与1159 nM*min),而其他CAT参数(峰值、滞后时间、达到峰值的时间和速度指数)以及基本凝血试验均在正常范围内。抗磷脂抗体的存在和所应用的治疗与SLE患者的止血参数无关。我们得出结论,报道的高血栓形成风险与TG潜力无关。